celecoxib has been researched along with sinomenine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JY; Chang, QY; Chu, R; Dai, KH; Duan, ZJ; Li, YL; Liu, Z; Mo, GQ; Zhang, ZF | 1 |
1 other study(ies) available for celecoxib and sinomenine
Article | Year |
---|---|
Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Celecoxib; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Morphinans; NF-kappa B; Pyrazoles; Signal Transduction; Sulfonamides | 2014 |